EcoDrugPlus

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSDLAG00005020789
Gene Symbol: ROCK2
1 Cross references
216 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSDLAG00005012417
Gene Symbol: WEE1
1 Cross references
206 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSDLAG00005018833
Gene Symbol: ACVR2BA
1 Cross references
194 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSDLAG00005030532
Gene Symbol: ADORA2B
1 Cross references
199 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSDLAG00005011542
Gene Symbol: ADA
1 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSDLAG00005008439
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSDLAG00005002156
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDLAG00005033177
Gene Symbol: ADRA2B
1 Cross references
175 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDLAG00005007747
Gene Symbol: ADRA2C
1 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDLAG00005009553
Gene Symbol: ADRA2C
1 Cross references
162 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSDLAG00005021952
Gene Symbol: ADRB1
2 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSDLAG00005028975
Gene Symbol: ADRB2A
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).